From Yeast Patents (Class 435/224)
  • Patent number: 5108919
    Abstract: A ubiquitin hydrolase is provided having a purity of at least 70% homogeneity based on the weight of the total protein in the composition. Also provided are DNA sequences encoding ubiquitin hydrolases, as well as expression systems for their recombinant production. Processes are provided for purification of a ubiquitin hydrolase from eukaryotes and for its use in recovering any desired polypeptide free from its fusion at its N-terminus with ubiquitin.
    Type: Grant
    Filed: December 14, 1988
    Date of Patent: April 28, 1992
    Assignee: Genentech, Inc.
    Inventors: Chung-Cheng Liu, Harvey I. Miller
  • Patent number: 5104800
    Abstract: A process for the one-step conversion of cephalosporin C and derivatives thereof to the corresponding 7-aminocephalosporanic acid and derivatives comprising treating said cephalosporin C and derivatives with a cephalosporin C amidase enzyme of a recited sequence, the DNA encoding said enzyme, and expression thereof in a suitable host, e.g., Bacillus species under the control of a suitable promoter.
    Type: Grant
    Filed: June 27, 1989
    Date of Patent: April 14, 1992
    Assignee: Merck & Co., Inc.
    Inventors: Mark S. Crawford, David B. Finkelstein, John A. Rambosek
  • Patent number: 5100786
    Abstract: A gene which provides resistance to at least one methionine derivative and is capable of enhancing accumulation of S-adenosyl-L-methionine (SAM) in a cell, a hybrid plasmid having the same, a cell transformed with the above hybrid plasmid, and a process for producing SAM using the above cell. According to the present invention, SAM, which has various therapeutic effects, can be producing in a large amount at a low cost.
    Type: Grant
    Filed: December 23, 1988
    Date of Patent: March 31, 1992
    Assignee: Kanegafuchi Kagaku Kogyo Kabushiki Kaisha
    Inventors: Naofumi Shiomi, Hideki Fukuda
  • Patent number: 5077204
    Abstract: Methods and compositions are provided for endopeptidase production, enhanced efficiencies of processing in vivo and in vitro to provide for process polypeptides, and purified enzyme for in vitro processing of polypeptides. The endopeptidase is specific for dibasic amino acid sites, cleaving at the C-side of the dipeptide.The S. cerevisiae strain pYBCA-5 (truncated KEX2) was deposited at the A.T.C.C. on June 21, 1984 and given Accession No. 20717.
    Type: Grant
    Filed: April 8, 1988
    Date of Patent: December 31, 1991
    Assignees: Chiron Corporation, The Regents of the University of California
    Inventors: Anthony J. Brake, Lindley C. Blair, David Julius, Jeremy W. Thorner
  • Patent number: 5053333
    Abstract: There is disclosed a protease having the following enzymatic properties in view of:(a) function and substrate specificity,(b) optimum pH,(f) activation, and(g) inhibition;(a) the protease can hydrolyze, in particular, a peptide bond on the C-terminal side of Y of a peptide X--Y--, in which X is Arg, Lys or Pro optionally having a peptide bond on the N-terminal side, Y is Arg and -- indicates a peptide bond;(b) the protease has an optimum pH of about 7.0 in Tris hydrochloride buffer;(f) the protease is activated with calcium chloride or a surfactant; and(g) the protease is inhibited with p-amidinophenylmethanesulfonyl fluoride, p-chloromercuribenzoic acid, a metal chelater, tetraacetic acid or a heavy metal.
    Type: Grant
    Filed: January 26, 1989
    Date of Patent: October 1, 1991
    Assignee: M & D Research Co., Ltd.
    Inventor: Hiroaki Yamamoto
  • Patent number: 4977085
    Abstract: A method is provided for expressing the proteases dipeptidyl aminopeptidases A and B which are useful for processing precursor proteins. Genes controlling these proteases may be insdrted into appropriate vectors and transformed into cultures. The proteases may either be utilized to process precursor proteins in vivo or may be extracted from cultures and used to process precursor proteins in vitro.
    Type: Grant
    Filed: February 29, 1984
    Date of Patent: December 11, 1990
    Assignee: The Board of Regents of the Univ. of California
    Inventors: George Sprague, Ira Herskowitz, Jeremy Thorner, David Julius, Lindley Blair, Anthony Brake
  • Patent number: 4961938
    Abstract: Cheese is prepared using rennin obtained from insoluble refractile bodies of a recombinant microbial host cell. The rennin is obtained by rupturing the recombinant hose cell, isolating and solubilizing the insoluble refractile bodies, and recovering active rennin. Recombinant techniques involve preparing cDNA corresponding to the coding sequence for calf rennin, introducing into an expression vector and expressing in a host cell. As much as 200 mg rennin per liter of culture may be recovered. Prorennin or preprorennin may be produced and rennin derived therefrom.
    Type: Grant
    Filed: June 3, 1987
    Date of Patent: October 9, 1990
    Assignee: Genentech, Inc.
    Inventors: Kirk J. Hayenga, Virgil B. Lawlis, Bradley R. Snedecor
  • Patent number: 4935354
    Abstract: Rennin for making cheese is obtained from insoluble refractile bodies of a recombinant microbial host cell. The rennin is obtained by rupturing the recombinant host cell, isolating and solubilizing the insoluble refractile bodies, and recovering active rennin. Recombinant techniques involve preparing cDNA corresponding to the coding sequence for calf rennin, introducing into an expression vector and expressing in a host cell. As much as 200 mg rennin per liter of culture may be recovered. Prorennin or preprorennin may be produced and rennin derived therefrom.
    Type: Grant
    Filed: November 5, 1986
    Date of Patent: June 19, 1990
    Assignee: Genentech, Inc.
    Inventors: Kirk J. Hayenga, Virgil B. Lawlis
  • Patent number: 4879235
    Abstract: A process for producing protease by cultivating a protease-producing mold in a liquid medium, which is characterized by continuously adding a liquid medium containing a protein material to the culture medium after the substantial termination of proliferation of the mold cells.
    Type: Grant
    Filed: November 21, 1986
    Date of Patent: November 7, 1989
    Assignee: The Japanese Research and Development Association for Bioreactor System
    Inventors: Hiroshi Motai, Yaichi Fukushima, Tetsuro Fukase, Harumichi Itoh
  • Patent number: 4650763
    Abstract: Disclosed is a new protease having the following properties: (1) it is able to hydrolitically cleave a peptide bond between two adjacent basic amino acids in a peptide chain; (2) it has a molecular weight of about 43,000 as determined by electrophoresis; (3) it is inhibited by phenylmethylsulphonyl fluoride and diisopropyl fluorophosphate, but is not inhibited by monoiodoacetate, p-chloromercuribenzoic acid, ethylenediaminetetraacetic acid, 1,10-phenanthroline, tosyl-L-lysine chloromethyl ketone, and leupeptin. The protease can be produced by culturing Saccharomyces cerevisiae, and recovering purification by conventional methods, and is useful as a processing enzyme for conversion of a prohormone to an active hormone.
    Type: Grant
    Filed: April 12, 1985
    Date of Patent: March 17, 1987
    Assignee: Suntory Limited
    Inventors: Hisayuki Matsuo, Kensaku Mizuno, Takaharu Tanaka
  • Patent number: 4393139
    Abstract: The present invention provides a process for the selective separation of endoproteases from aqueous solutions, wherein an aqueous solution containing proteases is treated with a complex, present in the solid phase, of alpha.sub.2 -macroglobulin with a divalent metal selected from zinc, cobalt, nickel and copper and the solid phase then separated off.The present invention also provides an agent for carrying out this process, wherein it comprises a solid carrier material which is loaded with a complex of alpha.sub.2 -macroglobulin and of a divalent metal selected from zinc, cobalt, nickel and copper.
    Type: Grant
    Filed: August 28, 1981
    Date of Patent: July 12, 1983
    Assignee: Boehringer Mannheim GmbH
    Inventors: Jurgen Schrenk, Peter Wunderwald